Literature DB >> 10704820

Structure and function of phosphatidylinositol-3,4 kinase.

M Funaki1, H Katagiri, K Inukai, M Kikuchi, T Asano.   

Abstract

Activation of phosphatidylinositol (PI)-kinase is involved in the regulation of a wide array of cellular activities. The enzyme exists as a dimer, consisting of a catalytic and a regulatory subunit. Five isoforms of the regulatory subunit have been identified and classified into three groups comprising respectively 85-kDa, 55-kDa, and 50-kDa proteins. Structural differences in the N-terminal regions of the different group members contribute to defining their binding specificity, their subcellular distributions, and their capacity to activate the 110-kDa catalytic subunit. Two widely distributed isoforms of the catalytic subunit have been identified-p110alpha and p110beta. Despite the fact that they bind to the p85alpha regulatory subunit similarly, p110alpha and p110beta appear to have separate functions within cells and to be activated by different stimuli. Moreover, although p85/p110 PI-kinase almost exclusively phosphorylates the D-3 position of the inositol ring in phosphoinositides when purified PI is used as a substrate in vitro, it appears to phosphorylate the D-4 position with similar or higher efficiency in vivo. Thus, it is highly probable that p85/p110 PI-kinase transmits signals to downstream targets via both D-3- and D-4-phosphorylated phosphoinositides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704820     DOI: 10.1016/s0898-6568(99)00086-8

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.

Authors:  Ricky Cheung; Vipa Ravyn; Lingshu Wang; Andrzej Ptasznik; Ronald G Collman
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

2.  Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.

Authors:  Victoria Rotter Sopasakis; Pixu Liu; Ryo Suzuki; Tatsuya Kondo; Jonathon Winnay; Thien T Tran; Tomoichiro Asano; Graham Smyth; Mini P Sajan; Robert V Farese; C Ronald Kahn; Jean J Zhao
Journal:  Cell Metab       Date:  2010-03-03       Impact factor: 27.287

3.  The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor.

Authors:  Mihail S Iordanov; Remy J Choi; Olga P Ryabinina; Thanh-Hoai Dinh; Robert K Bright; Bruce E Magun
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

4.  An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages.

Authors:  Ricky Cheung; Mobeen Malik; Vipa Ravyn; Brian Tomkowicz; Andrzej Ptasznik; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2009-07-20       Impact factor: 4.962

5.  Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.

Authors:  Veerendra Munugalavadla; Emily C Sims; Jovencio Borneo; Rebecca J Chan; Reuben Kapur
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

6.  Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.

Authors:  Rita Sulahian; Ondine Cleaver; Lily Jun-shen Huang
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

7.  Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.

Authors:  Sarah M Leiter; Victoria E R Parker; Alena Welters; Rachel Knox; Nuno Rocha; Graeme Clark; Felicity Payne; Luca Lotta; Julie Harris; Julio Guerrero-Fernández; Isabel González-Casado; Sixto García-Miñaur; Gema Gordo; Nick Wareham; Víctor Martínez-Glez; Michael Allison; Stephen O'Rahilly; Inês Barroso; Thomas Meissner; Susan Davies; Khalid Hussain; Karen Temple; Ana-Coral Barreda-Bonis; Sebastian Kummer; Robert K Semple
Journal:  Eur J Endocrinol       Date:  2017-05-31       Impact factor: 6.664

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.